Is 'Ozempic Face' Real? The Controversial Side Effect of a Popular Weight Loss Drug

Photo byzelkeninstitute.com

The buzz around appetite-suppressing drugs like Ozempic has skyrocketed thanks to social media, but as these medications gain popularity, it's crucial to remember that scientific understanding of their effects is still evolving.

Many individuals are sharing their experiences online, highlighting both the benefits and unexpected side effects. One such side effect gaining attention on social media is the so-called 'Ozempic face' – characterized by hollowed-out cheeks, sunken eyes, and sagging skin following significant, rapid weight loss.

This term has dominated media discussions for over a year, with some experts arguing that it is misleading and potentially discouraging people from using a drug that could significantly benefit their health, beyond weight loss.

What Is Ozempic?

Ozempic and Wegovy belong to a class of drugs known as glucagon-like peptide-1 receptor (GLP-1) agonists. These medications help regulate blood sugar levels and suppress appetite by mimicking a natural hormone in the body. Originally developed to treat diabetes, these injectables are now frequently prescribed off-label for weight loss.

The Controversy of 'Ozempic Face'

The debate centers around whether facial changes are a direct side effect of GLP-1 agonists or simply a result of rapid weight loss, similar to what occurs after bariatric surgery.

Currently, there is no scientific evidence indicating that GLP-1 agonists specifically target facial fat. Clinical trials have not yet measured the prevalence or severity of these facial changes, leaving the phenomenon largely undocumented outside of social media anecdotes.

Some experts contend that the term is offensive and derogatory, which may deter patients from using a medication that could improve their health.

Rapid Weight Loss and Facial Changes

It is well-known that significant, rapid weight loss can lead to excess skin around the temples, cheeks, eyes, jawline, and mouth, causing sagging and wrinkles. Diet and hydration also play roles in how the skin appears during weight loss. Furthermore, GLP-1 agonists can potentially alter the size of a person's lips, cheeks, and chin, independent of fat loss.

Research suggests that individuals experiencing massive weight loss often look several years older than those who maintain their weight. This could be what's happening with Ozempic and similar medications, but more studies are needed, especially focusing on those without diabetes.

Should 'Ozempic Face' Be a Concern?

Endocrinologist Dr. Aoife Egan argues that the term 'Ozempic face' is not a medical term and should not deter patients from using GLP-1 agonists. Egan emphasizes that she has not had any patients express concerns about their facial appearance while on these medications.

Experts agree that a well-balanced diet and controlled weight loss can mitigate these facial changes. The potential for skin changes shouldn't overshadow the significant health benefits of GLP-1 agonists.

The Takeaway

The conversation around 'Ozempic face' underscores the importance of nuanced, evidence-based discussions about new medications. While social media can amplify certain side effects, it's essential to consult healthcare professionals and consider the overall benefits and risks.

Ultimately, understanding and addressing the root causes of these changes, whether through careful weight management or medical advice, can help patients make informed decisions about their health.